[BREAKING] [Exclusive] Ginom & Company's patent new drug Nostratus dilator is urgently approved, and it is the first acquired body structure treatment based on microbiome.

1 April Share

[BREAKING] [Exclusive] Ginom & Company's patent new drug Nostratus dilator is urgently approved, and it is the first acquired body structure treatment based on microbiome.

[単独] ジノムアンドカンパニー特許新薬鼻の穴拡張剤緊急承認、マイクロバイオム基盤初の後天性身体構造治療剤。

[单独] GENOME&COMPANY 专利新药鼻孔扩张剂紧急批准,以微生物组为基础的首个后天性身体结构治疗剂。

[Только] Патент Genome & Company на расширение носа, первый в своем роде метод лечения физической структуры на основе микробиома.

[단독] 지놈앤컴퍼니 특허신약 콧구멍확장제 긴급승인, 마이크로바이옴 기반 최초의 후천성 신체구조 치료제. [More News]